Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Stage

Acquired Unit | Acquired

Valuation

$0000 

About Galena Biopharma - Zuplenz

Galena Biopharma (Nasdaq: GALE) is a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care.

Galena Biopharma - Zuplenz Headquarters Location

2000 Crow Canyon Place Suite 380

San Ramon, California, 94583,

United States

855-855-4253

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Galena Biopharma - Zuplenz

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Galena Biopharma - Zuplenz is included in 1 Expert Collection, including Cancer.

C

Cancer

1,179 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

  • Where is Galena Biopharma - Zuplenz's headquarters?

    Galena Biopharma - Zuplenz's headquarters is located at 2000 Crow Canyon Place, San Ramon.

  • What is Galena Biopharma - Zuplenz's latest funding round?

    Galena Biopharma - Zuplenz's latest funding round is Acquired Unit.

  • Who are the investors of Galena Biopharma - Zuplenz?

    Investors of Galena Biopharma - Zuplenz include Midatech Pharma.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.